HBx inhibits the expression of LINC01352, which increases the expression of miR-135b, thereby reducing adenomatous polyposis (APC) production and further activating the Wnt/β-catenin signaling pathway, promoting the progression of HBV-associated hepatocellular carcinoma 38. The gene discussed is LINC01352; the disease is hepatocellular carcinoma.